Access cutting-edge diabetes mellitus, type 2 treatment through this phase 3 clinical trial at a research site in Topeka. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Topeka location
Preparing your pre-screening questions…
Access diabetes mellitus, type 2 specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related diabetes mellitus, type 2 treatment provided free
Check if you qualify for this diabetes mellitus, type 2 clinical trial in Topeka, KS
No-Cost Study Care
Local to Topeka
Convenient for KS residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study looks at how well a medicine called orforglipron works compared to another medicine called dulaglutide in pediatric participants aged 10 to less than 18 years with type 2 diabetes. The study will also check how safe these medicines are and how the body processes them. Participation in the study will last about 61 weeks.
Sponsor: Eli Lilly and Company
Yes, this clinical trial (NCT07668336) has an active research site in Topeka, KS that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for diabetes mellitus, type 2 treatment options in Topeka, KS, this clinical trial (NCT07668336) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Topeka research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced diabetes mellitus, type 2 specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all diabetes mellitus, type 2 clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Topeka — not just this study.
Browse Pulmonary Embolism Trials in Topeka →